First-year milestones for a regenerative injectable aesthetic filler, covering market rollout, scientific data, and global expansion plans.
Key Takeaways
- Product exceeded 150,000 syringes delivered across China within its first year
- It became the first China-developed injectable CaHA microsphere filler to receive EU-MDR certification
- Company partnered with over 620 clinics and certified more than 700 doctors nationwide